Article Versions Notes

Vallejo C, Meaney C, Clemens L, Yang K, Lukacova V, Zhou H. Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. Pharmaceutics. 2025; 17(3):372. https://doi.org/10.3390/pharmaceutics17030372

Vallejo, Celeste, Cameron Meaney, Lara Clemens, Kyunghee Yang, Viera Lukacova, and Haiying Zhou. 2025. "Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations" Pharmaceutics 17, no. 3: 372. https://doi.org/10.3390/pharmaceutics17030372

Vallejo, C., Meaney, C., Clemens, L., Yang, K., Lukacova, V., & Zhou, H. (2025). Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. Pharmaceutics, 17(3), 372. https://doi.org/10.3390/pharmaceutics17030372